Organization
A.C. Camargo Cancer Center
19 abstracts
Abstract
Cancer outcomes from a real-world cohort of patients eligible for adjuvant CDK4/6 inhibitors but without genomic risk for chemotherapy: A GBECAM multicenter retrospective study.Org: Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Hospital Moinhos de Vento, Sírio Libanês Hospital, Hospital Sírio-Libanês, A.C. Camargo Cancer Center,
Abstract
Overall survival in older patients with urologic cancer using G8 and G8m in a Brazilian cancer center.Org: A.C. Camargo Cancer Center, São Paulo, Brazil,
Abstract
Real life comparison between doxorubicin and cyclophosphamide (AC) dose-dense (dd) and conventional dose AC in patients with triple negative breast cancer (TNBC) under neoadjuvant treatment.Org: A.C. Camargo Cancer Center, São Paulo, Brazil, Brazil,
Abstract
Combined EORTC FDG-PET/CT and RECIST 1.1 response criteria and prediction of pathological response to neoadjuvant nivolumab and ipilimumab for clinical stage III melanoma.Org: A.C. Camargo Cancer Center, Melanoma Institute Australia,
Abstract
Retrospective study on the profile of patients undergoing intraoperative radiotherapy with INTRABEAM for breast cancer treatment at a Brazilian cancer center.Org: A.C. Camargo Cancer Center,
Abstract
Analysis of risk factors for recurrence within 12 months after surgery in patients with breast cancer receiving neoadjuvant therapy at a Brazilian cancer center.Org: A.C. Camargo Cancer Center, São Paulo, Brazil,
Abstract
Clinical and epidemiological profile of patients with atypical melanomas treated with immunotherapy.Org: A.C. Camargo Cancer Center, São Paulo, Brazil,
Abstract
Analysis of neoadjuvant nivolumab and ipilimumab for clinical stage III melanoma using the SWOG S1801 event-free survival definition.Org: A.C. Camargo Cancer Center, São Paulo, Brazil,
Abstract
Implementation of a comprehensive genomic profiling (CGP) panel for precision oncology at a cancer center in Brazil.Org: A.C. Camargo Cancer Center, Illumina, Inc.,
Abstract
A single-arm, multi-institutional, phase 2 study of a pembrolizumab-based organ preservation strategy for locally advanced larynx cancers: SMART-KEY (LACOG 0720) trial.Org: A.C. Camargo Cancer Center, Hospital de Amor de Barretos, Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Liga Norte Riograndense Contra o Câncer, Centro Regional Integrado de Oncologia (CRIO),
Abstract
Clinical implications of molecular alterations in intraductal carcinoma of the prostate.Org: Fox Chase Cancer Center, Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy, Caris Life Sciences, Irving, TX, Oncologia D`Or, A.C. Camargo Cancer Center,
Abstract
Clinical-pathological characterization of patients with HER2 negative breast cancer submitted to adjuvant docetaxel/cyclophosphamide (TC), TC4 versus TC6.Org: A.C. Camargo Cancer Center,
Abstract
FDG-PET/CT response and prediction of pathological response to neoadjuvant nivolumab and ipilimumab for clinical stage III melanoma.Org: A.C. Camargo Cancer Center, São Paulo, Brazil, Hospital Beneficência Portuguesa de São Paulo, São Paulo, Brazil, Beneficencia Portuguesa, AC Camargo Cancer Center,
Abstract
Characterization of patients with recurrent breast cancer submitted to neoadjuvant therapy in a Brazilian cancer center.Org: A.C. Camargo Cancer Center, Hospital ACCamargo, A.C. Camargo Hospital,
Abstract
Immunotherapy versus tyrosine kinase inhibitors in advanced hepatocellular carcinoma in first-line setting: A systematic review and meta-analysis of randomized controlled trials.Org: A.C. Camargo Cancer Center, Federal University of Rio de Janeiro, Faculdade de Medicina de Barbacena FAME - FUNJOB,
Abstract
Clinical and pathological description of patients with triple negative breast cancer undergoing neoadjuvant chemotherapy and pembrolizumab in a Brazilian cancer center.Org: A.C. Camargo Cancer Center,
Abstract
Retreatment with EGFR inhibitor in non-small cell lung cancer patients previously exposed to EGFR-TKI: A systematic review and meta-analysis.Org: Catholic University of Pelotas, Princess Margaret Hospital, Universidade de Brasília, Centro de Oncologia do Parana, Universidade Estadual do Centro Oeste - UNICENTRO, Guarapuava, Brazil,
Abstract
Safety and serum estradiol levels in hormonal treatments for vulvovaginal atrophy in breast cancer survivors: A systematic review and meta-analysis.Org: A.C. Camargo Cancer Center, Faculdade de Medicina de Barbacena FAME-FUNJOB, Universidade Federal do Rio Grande do Norte, Federal University of Rio de Janeiro, Mayo Clinic,
Abstract
Comparative analysis between the 8th and 7th AJCC as a prognostic tool for patients diagnosed with nonmetastatic head and neck soft-tissue sarcoma.Org: A.C. Camargo Cancer Center, Hospital ACCamargo,